课题基金 / 基金详情

University of Maryland Development Research Program

University of Maryland Development Research Program
马里兰大学发展研究计划
批准号:
8233368
负责人:
Myron Max Levine
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2014-02-28

项目摘要

项目成果

Myron Max Levine的其他基金

相似基金

相关文献

中文摘要
翻译
MARCE发展研究计划的主要目标是测试创新概念, 开发新技术,支持具有"高收益"潜力的"高风险"机会 在生物防御和新兴传染病研究的广泛领域取得了新的成果。所有申请人 对于论文奖将被期望与他们的发展项目计划的过度主题, MARCE,“新兴的病原体-宿主相互作用”,以及我们的研究计划之一。年级 1,MARCE将征集五项发展研究奖的申请,金额为120,000美元 每项为期2年,以支持诊断程序(VI)。项目将受到鼓励,适用于新的 通过广谱平台检测项目中正在研究的制剂或毒素的技术 - V.在第三年,发展研究奖的项目将被征集,重点是新兴技术 和新颖的概念,可以整合在任何6个研究计划。一次外部审查 委员会将协助申请审查过程。监测和评估 选定项目的进展将确保该计划取得成功。总体而言,发展研究 预计该计划将以几种方式加强和支持MARCE战略计划。第一,加法 新的研究人员和机构的MARCE将补充现有的相互作用, MARCE研究人员将为该领域注入新的想法和新的视角。第二,合并 将这些新项目纳入MARCE将进一步扩大研究组合的范围。三是 发展研究项目将通过以下方式加强现有研究项目的协同作用: 作为联系方案项目主题的桥梁,并提供新方法, 适用于多个项目。最终,获得这些奖项的调查人员将提高整体 这一领域的合格研究人员。此外,这些奖项的获得者将成为 MARCE研究人员网络,他们交流想法并扩大合作领域, 可以通过在MARCE会议和培训活动中的直接互动。正如第一次世界大战期间的情况一样, 在资助期间,将鼓励受助人利用他们通过 这些奖项支持的研究,以获得额外的竞争性赠款支持。以这种方式 最成功的研究项目和有前途的新技术可以扩大和推广, 生物防御和新兴传染病研究的好处。
英文摘要
The key objectives of the MARCE Developmental Research Plan are to test innovative concepts, develop new technologies, and support "high-risk" opportunities that demonstrate potential for "highyield" novel results in the broad area of biodefense and emerging infectious diseases research. All applicants for theses Awards will be expected to relate their Developmental Project plans to the over-arching theme of the MARCE, "Emerging pathogen-host interactions", as well as to one of our Research Programs. In year 1, the MARCE will solicit applications for five Developmental Research Awards in the amount of $120,000 each for 2 years to support the Diagnostics Program (VI). Projects will be encouraged that apply novel technologies through broad-spectrum platforms for the detection of agents or toxins under study in Programs -V. In year 3, Developmental Research Awards projects will be solicited that focus on emergent technologies and novel concepts and that can integrate within any of the 6 Research Programs. An external review committee will assist in the application review process. A structured system to monitor and evaluate the progress of the selected projects will ensure the success of the Plan. Overall, the Developmental Research Plan is anticipated to enhance and support the MARCE Strategic Plan in several ways. First, the addition of new investigators and institutions to MARCE will complement the existing interactions among established MARCE researchers and will inject fresh ideas and new perspectives into the field. Second, the incorporation of these new projects into MARCE will further expand the scope of the research portfolio. Third, the Developmental Research Projects will enhance synergies within the existing Research Programs by serving as bridges to link programmatic project themes and by providing new methodologies that may be applicable to several projects. Ultimately, the investigators who receive these Awards will increase the overall pool of qualified researchers in this field. In addition, the recipients of these Awards will become part of the network of MARCE investigators whose exchange of ideas and expanded areas of collaboration are made possible via direct interaction at MARCE meetings and training events. As was the case during the first funding period, recipients will be encouraged to exploit the preliminary data that they generated through research supported by these Awards into the acquisition of additional competitive grant support. In this way the most successful research projects and promising new technologies can be amplified and extended for the benefit of biodefense and emerging infectious disease research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
  • 批准号:
    9893801
  • 项目类别:
  • 资助金额:
    $250.0万
  • 财政年份:
    2019
  • 负责人:
    Myron Max Levine
  • 依托单位:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
  • 批准号:
    10584474
  • 项目类别:
  • 资助金额:
    $250.0万
  • 财政年份:
    2019
  • 负责人:
    Myron Max Levine
  • 依托单位:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
  • 批准号:
    10364708
  • 项目类别:
  • 资助金额:
    $250.0万
  • 财政年份:
    2019
  • 负责人:
    Myron Max Levine
  • 依托单位:
Administrative Core
  • 批准号:
    10364709
  • 项目类别:
  • 资助金额:
    $32.0万
  • 财政年份:
    2019
  • 负责人:
    Myron Max Levine
  • 依托单位:
海外基金